Authors: TOTH K VAUGHAN MM SCHWARTZ G WINSTON JS SKENDERIS BS SLOCUM HK RUSTUM YM

Citation: K. Toth et al., EXPRESSION OF THE MRP AND MDR1 MULTIDRUG-RESISTANCE GENE-PRODUCTS IN 160 UNTREATED HUMAN CARCINOMAS STUDIED BY IMMUNOHISTOCHEMICAL METHODS IN FORMALIN-PARAFFIN SECTIONS, International journal of surgical pathology, 6(3), 1998, pp. 145-154

Authors: YIN MB GUO B VOIGT W VANHOEFER U GIBBS JF SKENDERIS BS FRANK C WRZOSEK C RUSTUM YM

Citation: Mb. Yin et al., NOVEL CELLULAR DETERMINANTS FOR REVERSAL OF MULTIDRUG-RESISTANCE IN CELLS EXPRESSING P170-GLYCOPROTEIN, Biochimica et biophysica acta. Molecular cell research, 1401(3), 1998, pp. 265-276

Authors: VANHOEFER U CAO SS MINDERMAN H TOTH K SKENDERIS BS SLOVAK ML RUSTUM YM

Citation: U. Vanhoefer et al., D,L-BUTHIONINE-(S,R)-SULFOXIMINE POTENTIATES IN-VIVO THE THERAPEUTIC EFFICACY OF DOXORUBICIN AGAINST MULTIDRUG-RESISTANCE PROTEIN-EXPRESSING TUMORS, Clinical cancer research, 2(12), 1996, pp. 1961-1968

Authors: SARDI A BOLTON JS HICKS TC SKENDERIS BS

Citation: A. Sardi et al., TOTAL PELVIC EXENTERATION WITH OR WITHOUT SACRAL RESECTION IN PATIENTS WITH RECURRENT COLORECTAL-CANCER, Southern medical journal, 87(3), 1994, pp. 363-369